Following the recent Institute of Medicine report recommending a replacement of the Food and Drug Administration's 510(k) process for approving medical devices, John Smith, a partner in the law firm Hogan Lovells, sent out a client alert outlining his thoughts.
In a nutshell, Smith finds the IOM's conclusions unrealistic and based on false assumptions, but with some recommendations of value. Here are his thoughts:
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access